New Quinazolin-4(3H)-One Derivatives Incorporating Isoxazole Moiety as Antioxidant Agents: Synthesis, Structural Characterization, and Theoretical DFT Mechanistic Study
<b>Background</b>: This research centers on the development and spectroscopic characterization of new quinazolin-4(3H)-one-isoxazole derivatives (<b>5a-e</b>). The aim was to investigate the regioselectivity of the 1,3-dipolar cycloaddition involving arylnitriloxides and N-propargylquinazolin-4(3H)-one, and to assess the antioxidant properties of the synthesized compounds. The synthetic approach started with the alkylation of quinazolin-4(3H)-one using propargyl bromide, followed by a 1,3-dipolar cycloaddition reaction. <b>Methods</b>: The structural identification of the products was performed using various spectroscopic methods, such as IR, 1H, 13C, and HMBC NMR, HRMS, and single-crystal X-ray diffraction. To further examine the regioselectivity of the cycloaddition, Density Functional Theory (DFT) calculations at the B3LYP/6-31G(d) level were employed. Additionally, the antioxidant potential of the compounds was tested in vitro using DPPH (2,2-Diphenyl-1-picrylhydrazyl)radical scavenging assays. The reaction selectively produced 3,5-disubstituted isoxazoles, with the regiochemical outcome being independent of the substituents on the phenyl ring. <b>Results</b>: Theoretical calculations using DFT were in agreement with the experimental results, revealing activation energies of -81.15 kcal/mol for P-1 and -77.32 kcal/mol for P-2, favoring the formation of P-1. An analysis of the Intrinsic Reaction Coordinate (IRC) confirmed that the reaction proceeded via a concerted but asynchronous mechanism. The antioxidant tests demonstrated that the synthesized compounds exhibited significant radical scavenging activity, as shown in the DPPH assay. The 1,3-dipolar cycloaddition of arylnitriloxides with N-propargylquinazolin-4(3H)-one successfully resulted in novel 3,5-disubstituted isoxazoles. <b>Conclusions</b>: The experimental findings were well-supported by theoretical predictions, and the antioxidant assays revealed strong activity, indicating the potential for future biological applications of these compounds.
Authors
- Bouchra Es‐Sounni (ORCID: https://orcid.org/0000-0002-0768-9686)
- Riham Sghyar
- Yassine Rhazi (ORCID: https://orcid.org/0000-0001-7245-9468)
- Asmae Nakkabi (ORCID: https://orcid.org/0000-0002-9845-243X)
- Mohamed El Yazidi (ORCID: https://orcid.org/0000-0002-2772-6632)
- Khalil Hammani (ORCID: https://orcid.org/0000-0002-4005-4244)
- Samir Chtita (ORCID: https://orcid.org/0000-0003-2344-5101)
- Albert Soran (ORCID: https://orcid.org/0000-0002-7710-7776)
- Noémi Deak (ORCID: https://orcid.org/0000-0002-9401-0298)
- Mohammed M. Alanazi (ORCID: https://orcid.org/0000-0002-0483-8113)
- Gabriela Nemeş (ORCID: https://orcid.org/0000-0003-4031-594X)
- Bouchra Rossafi
- Mustapha Laghmari
- Azize Arzine
Institutions
- King Saud University (SA)
- Babeș-Bolyai University (RO)
- Université Moulay Ismail de Meknes (MA)
- Sidi Mohamed Ben Abdellah University (MA)
- University of Hassan II Casablanca (MA)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2024-10-18
- DOI
- https://doi.org/10.3390/ph17101390
- Citations
- 7
- Primary Topic
- Synthesis and Characterization of Heterocyclic Compounds
- Type
- article
- Field-Weighted Citation Impact
- 1.75
Funders
- King Saud University